Thiele, H. and Akin, I. and Sandri, M. and Fuernau, G. and de Waha, S. and Meyer-Saraei, R. and Nordbeck, P. and Geisler, T. and Landmesser, U. and Skurk, C. and Fach, A. and Lapp, H. and Piek, J. J. and Noc, M. and Goslar, T. and Felix, S. B. and Maier, L. S. and Stepinska, J. and Oldroyd, K. and Serpytis, P. and Montalescot, G. and Barthelemy, O. and Huber, K. and Windecker, S. and Savonitto, S. and Torremante, P. and Vrints, C. and Schneider, S. and Desch, S. and Zeymer, U. (2017) PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock. NEW ENGLAND JOURNAL OF MEDICINE, 377 (25). pp. 2419-2432. ISSN 0028-4793, 1533-4406
Full text not available from this repository. (Request a copy)Abstract
BACKGROUND In patients who have acute myocardial infarction with cardiogenic shock, early revascularization of the culprit artery by means of percutaneous coronary intervention (PCI) improves outcomes. However, the majority of patients with cardiogenic shock have multivessel disease, and whether PCI should be performed immediately for stenoses in nonculprit arteries is controversial. METHODS In this multicenter trial, we randomly assigned 706 patients who had multivessel disease, acute myocardial infarction, and cardiogenic shock to one of two initial revascularization strategies: either PCI of the culprit lesion only, with the option of staged revascularization of nonculprit lesions, or immediate multivessel PCI. The primary end point was a composite of death or severe renal failure leading to renal-replacement therapy within 30 days after randomization. Safety end points included bleeding and stroke. RESULTS At 30 days, the composite primary end point of death or renal-replacement therapy had occurred in 158 of the 344 patients (45.9%) in the culprit-lesion-only PCI group and in 189 of the 341 patients (55.4%) in the multivessel PCI group (relative risk, 0.83; 95% confidence interval [CI], 0.71 to 0.96; P = 0.01). The relative risk of death in the culprit-lesion-only PCI group as compared with the multivessel PCI group was 0.84 (95% CI, 0.72 to 0.98; P = 0.03), and the relative risk of renal-replacement therapy was 0.71 (95% CI, 0.49 to 1.03; P = 0.07). The time to hemodynamic stabilization, the risk of catecholamine therapy and the duration of such therapy, the levels of troponin T and creatine kinase, and the rates of bleeding and stroke did not differ significantly between the two groups. CONCLUSIONS Among patients who had multivessel coronary artery disease and acute myocardial infarction with cardiogenic shock, the 30-day risk of a composite of death or severe renal failure leading to renal-replacement therapy was lower among those who initially underwent PCI of the culprit lesion only than among those who underwent immediate multivessel PCI. (Funded by the European Union 7th Framework Program and others; CULPRIT-SHOCK ClinicalTrials.gov number, NCT01927549.)
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | PERCUTANEOUS CORONARY INTERVENTION; MULTIVESSEL DISEASE; EARLY REVASCULARIZATION; ANGIOGRAPHIC FINDINGS; RANDOMIZED-TRIAL; CULPRIT LESION; OPEN-LABEL; ANGIOPLASTY; MANAGEMENT; SURVIVAL; |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Innere Medizin II |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 14 Dec 2018 13:18 |
| Last Modified: | 28 Feb 2019 11:32 |
| URI: | https://pred.uni-regensburg.de/id/eprint/1676 |
Actions (login required)
 |
View Item |
